Mount Sinai Medical Center

Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

Retrieved on: 
Thursday, February 15, 2024

HOLON, Israel, Feb. 15, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the appointment of Michelle Mahler, M.D., as Chief Medical Officer, effective March 1, 2024.

Key Points: 
  • HOLON, Israel, Feb. 15, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the appointment of Michelle Mahler, M.D., as Chief Medical Officer, effective March 1, 2024.
  • Michelle will succeed Henry Adewoye, M.D., who is leaving Compugen to pursue other opportunities effective February 29, 2024, after 6 years with Compugen.
  • "I am delighted that Michelle will join the management team as Chief Medical Officer at a very exciting time for Compugen," said Anat Cohen-Dayag, Ph.D., President, and Chief Executive Officer of Compugen.
  • Michelle obtained her medical degree from University of the Witwatersrand, South Africa and is a board-certified pediatric hematologist and oncologist.

The Inner Circle Acknowledges, Paul V. Sunkavalli as a Pinnacle Lifetime Member

Retrieved on: 
Monday, February 12, 2024

MANAHAWKIN, N.J., Feb. 12, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Paul V. Sunkavalli is acknowledged as a Pinnacle Lifetime Member for his contributions to the field of Pediatrics.

Key Points: 
  • MANAHAWKIN, N.J., Feb. 12, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Paul V. Sunkavalli is acknowledged as a Pinnacle Lifetime Member for his contributions to the field of Pediatrics.
  • Dr. Sunkavalli pursued higher education at St. Mary's College where he earned a double major in biology and chemistry after transferring from Baylor University.
  • He received a Doctor of Medicine degree from Spartan Health Sciences University in St. Lucia; completed a Pediatric residency at Mount Sinai Medical Center (Jersey City Program).
  • Dr. Sunkavalli asserts that he is inspired by his entire family, including his father, Dr. Krishna Sunkavalli and his wife Dr. Anupama Sunkavalli.

Mount Sinai Medical Center First to Utilize AI Technology to Treat Complex Aortic Conditions at South Florida's Only Aortic Center

Retrieved on: 
Monday, February 12, 2024

MIAMI BEACH, Fla., Feb. 8, 2024 /PRNewswire/ -- Mount Sinai Medical Center is proud to announce the implementation of unique AI software designed to support the treatment of patients with complex aortic disease.

Key Points: 
  • MIAMI BEACH, Fla., Feb. 8, 2024 /PRNewswire/ -- Mount Sinai Medical Center is proud to announce the implementation of unique AI software designed to support the treatment of patients with complex aortic disease.
  • As part of a collaboration between Cydar Medical and Medtronic, this software employs state-of-the-art minimally invasive endovascular technology that is being used by surgeons at Mount Sinai's Aortic Center.
  • The medical center currently stands as the first and only institution to use this technology in all of Eastern Florida.
  • "We are thrilled a medical center as renowned and respected as Mount Sinai has implemented our product into their clinical work," says Paul Mussenden, the CEO at Cydar Medical.

Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments

Retrieved on: 
Thursday, February 1, 2024

STUART, Fla., Feb. 1, 2024 /PRNewswire/ -- Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has appointed Jodi Luchs, MD to the position of Chief Medical Officer, and Don Stires to the position of Chief Financial Officer.

Key Points: 
  • STUART, Fla., Feb. 1, 2024 /PRNewswire/ -- Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has appointed Jodi Luchs, MD to the position of Chief Medical Officer, and Don Stires to the position of Chief Financial Officer.
  • With the appointment of Dr. Luchs, Robert Baratta, MD has stepped aside from his current role as Chief Medical Officer but will continue as Stuart's Executive Chairman of the Board.
  • "Stuart Therapeutics' growth, international operations and increase in pipeline opportunities require an expansion of our team and capabilities," said Eric Schlumpf, President and Chief Executive Officer of Stuart.
  • He completed an internship at the Mount Sinai Medical Center, and his Ophthalmology residency at Long Island Jewish Medical Center.

Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry

Retrieved on: 
Thursday, November 16, 2023

The registry will include appropriate patient selection and proper vascular access.

Key Points: 
  • The registry will include appropriate patient selection and proper vascular access.
  • Enrolling at least 250 patients in up to 15 major TAVR institutions across the US and Canada, the ACCESS-MANTA™ Registry is an international, multicenter, prospective, observational, single-arm clinical registry.
  • “Large bore access site complications are recognized as morbid,1 driving increased costs and prolonged length-of-stay,2” said Teleflex Interventional Medical Director, Christopher Buller, MD.
  • “We are excited that Mount Sinai Medical Center is spearheading the Teleflex ACCESS-MANTA™ Registry,” said Dr. Khera, Co-Global Principal Investigator.

ObservSMART Extends Service to Include Mount Sinai Medical Center's Emergency Centers

Retrieved on: 
Monday, December 11, 2023

ObservSMART is enjoying a partnership with Mount Sinai Medical Center and is looking forward to ensuring patient safety.

Key Points: 
  • ObservSMART is enjoying a partnership with Mount Sinai Medical Center and is looking forward to ensuring patient safety.
  • The Jay and Jeanie Schottenstien Center for Behavioral Health Department plays an essential role in Mount Sinai Medical Center's mission to provide high quality health care to our diverse community.
  • By incorporating ObservSMART into the behavioral health and emergency centers, Mount Sinai's continues their commitment to enhancing patient safety and the level of personalized care each patient receives.
  • The continued collaboration between Mount Sinai and ObservSMART highlights a focus on quality improvement, driven by healthcare innovation, data-driven insights, and a joint dedication to enhancing both staff and patient safety.

Seventy-One Percent of Persons With Type 2 Diabetes Say a Remote Patient Monitoring (RPM) Program Would Help Them Better Manage Their Health

Retrieved on: 
Friday, November 10, 2023

For the same question in the 2021 Diabetes Care Survey, only 35 percent of the respondents indicated that an RPM program would better help them manage their diabetes.

Key Points: 
  • For the same question in the 2021 Diabetes Care Survey, only 35 percent of the respondents indicated that an RPM program would better help them manage their diabetes.
  • The dramatic increase shows a rise in the awareness, ease of use, and effectiveness of a cellular remote glucose monitoring program.
  • The convenience of cellular-based glucose monitors enables better patient adherence to care plan instructions, leading to stabilized or improved outcomes.
  • With cellular-enabled remote glucose monitoring solutions from Smart Meter, providers are assured of getting the latest and most accurate data when a patient tests.

Cardiost, Inc. Strengthens Scientific Advisory Board with Renowned Cardiovascular Experts, Advances Prototype Development with OEDIT Grant Support

Retrieved on: 
Friday, September 29, 2023

Cardiost is currently designing an alpha prototype of its LAUD, or Left Atrium Unloading Device, with money it received from Colorado’s OEDIT grant in early 2023.

Key Points: 
  • Cardiost is currently designing an alpha prototype of its LAUD, or Left Atrium Unloading Device, with money it received from Colorado’s OEDIT grant in early 2023.
  • The LAUD is a durable mechanical circulatory support (MCS) device to treat late-stage patients suffering from heart failure (HF).
  • Cardiost is focused on developing cardiovascular devices medical devices in the cardiovascular space.
  • “We are thrilled to add Dr. Goldstein and Dr. Moreno to our Scientific Advisory Board, both KOLs in their respective fields – MCS the former and PCI the latter.

NBBJ Welcomes Commercial Market Leader Doug Hocking, AIA

Retrieved on: 
Monday, September 25, 2023

NEW YORK, Sept. 25, 2023 /PRNewswire/ -- NBBJ, a global architecture and design firm, announced today that Doug Hocking, AIA, has joined the firm as a Commercial Market Leader and Principal, based in New York.

Key Points: 
  • NEW YORK, Sept. 25, 2023 /PRNewswire/ -- NBBJ, a global architecture and design firm, announced today that Doug Hocking, AIA, has joined the firm as a Commercial Market Leader and Principal, based in New York.
  • As commercial development pivots in light of an evolving market, future demand will focus on healthy, carbon efficient buildings that create convenience and comfort for a new generation of occupants.
  • "Doug's groundbreaking approach to repositioning is uniquely valuable given today's urban context," said Robert Mankin, AIA, Managing Partner of NBBJ.
  • "As our cities begin to confront an aging building stock that doesn't meet the current needs of our clients, design creativity, paired with advances in technology, will allow us to adapt these buildings to meet the needs of the next generation," said Doug Hocking, AIA, Commercial Market Leader and Principal.

Susan G. Komen® Miami/Ft. Lauderdale MORE THAN PINK Walk Raises Funds for Breast Cancer Health Equity

Retrieved on: 
Thursday, September 14, 2023

This signature event enables Komen to raise critical funds that provide direct support to breast cancer patients, fund groundbreaking research, empower health equity initiatives nationwide, and advocate for change at both the state and federal government levels.

Key Points: 
  • This signature event enables Komen to raise critical funds that provide direct support to breast cancer patients, fund groundbreaking research, empower health equity initiatives nationwide, and advocate for change at both the state and federal government levels.
  • Lauderdale MORE THAN PINK Walk this year and provide a community for those impacted by breast cancer," said Sean Gross, State Executive Director at Susan G. Komen.
  • "Breast cancer is the leading cause of cancer death among Hispanic women in the U.S, and the Miami/Ft.
  • We look forward to raising funds that advance health equity outcomes and break down the barriers that create poor breast health outcomes for these communities."